Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 7, 2016; 22(25): 5814-5821
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5814
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5814
Table 1 Clinicopathological features of IHCC patients and the correlation between ARID1A protein expression and clinicopathological parameters
Characteristics | ARID1A | P value | |
Low expression | High expression | ||
n = 19 | n = 38 | ||
Age (yr) | 0.703 | ||
< 50 | 7 | 16 | |
≥ 50 | 12 | 22 | |
Sex | 0.546 | ||
Female | 7 | 11 | |
Male | 12 | 27 | |
Child-classification | 0.500 | ||
A | 15 | 34 | |
B | 4 | 4 | |
Differentiation | 0.546 | ||
Well | 10 | 12 | |
Moderately | 4 | 13 | |
Poorly | 5 | 13 | |
Tumor size (cm) | 0.306 | ||
> 3 | 15 | 25 | |
≤ 3 | 4 | 13 | |
Tumor nodule | < 0.001 | ||
Solitary | 7 | 32 | |
Multiple | 12 | 6 | |
Vein invasion | 0.004 | ||
Positive | 13 | 11 | |
Negative | 6 | 27 | |
Recurrence status | 0.004 | ||
Yes | 16 | 17 | |
No | 3 | 21 |
- Citation: Yang SZ, Wang AQ, Du J, Wang JT, Yu WW, Liu Q, Wu YF, Chen SG. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. World J Gastroenterol 2016; 22(25): 5814-5821
- URL: https://www.wjgnet.com/1007-9327/full/v22/i25/5814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i25.5814